StemCells

StemCells trial injecting cells into eye to treat AMD

Wednesday, May 28, 2014 11:37 AM

In a closely-watched clinical trial, StemCells said it has transplanted the company’s purified human neural stem cells into the first five patients in the final cohort of its 16-patient phase I/II trial for the advanced or dry form of age-related macular degeneration (AMD). 

More... »

WIRB Copernicus Group

Auspex Pharmaceuticals appoints Lynn Bleil, Scott Greer to board of directors

Friday, May 9, 2014 12:53 PM

Auspex Pharmaceuticals, a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, has announced the expansion of its board of directors with the appointment of two new members: Lynn D. Bleil, former leader of McKinsey & Company's West Coast Healthcare Practice and a leader of the worldwide Healthcare Practice; and R. Scott Greer, managing director of Numenor Ventures, and former founder, chairman and CEO of Abgenix. The total number of Auspex board members is increased to nine.

More... »

CRF Health eCOA webinar series

StemCells launches Alzheimer's program supported by CIRM

Wednesday, July 31, 2013 11:47 AM

StemCells has launched its Alzheimer's disease program, supported by the California Institute for Regenerative Medicine (CIRM). The goal is to file, within four years, an IND application with the FDA to evaluate the company's proprietary HuCNS-SC product candidate (purified human neural stem cells) as a potential therapeutic in the treatment of Alzheimer's disease.

More... »

StemCells announces first transplant of neural stem cells into patient with dry AMD

Thursday, October 11, 2012 07:00 AM

StemCells, a cell-based therapeutics company of Newark, Calif., has enrolled and transplanted stem cells into the first patient in its phase I/II clinical trial in dry age-related macular degeneration (AMD).

More... »

StemCells awarded $20M from CIRM for Alzheimer's program

Wednesday, September 12, 2012 10:52 AM

The California Institute for Regenerative Medicine (CIRM), which awards grants and loans for stem cell research, has approved an award to StemCells, a cell-based therapeutics company based in Newark, Calif., for up to $20 million under CIRM's Disease Team Therapy Development Award program (RFA 10-05).

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs